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The cystic fibrosis transmembrane conductance regulator
(CFTR)1 forms an ion channel that is permeable to Cl⫺ and
other large organic anions (1–3). Mutations in the gene encoding CFTR are responsible for cystic fibrosis, whose pathology
was thought to be due primarily to a decrease in Cl⫺ permeability through the CFTR (4). However, it is not clear how a
change in Cl⫺ permeability could account for the large variety
of symptoms observed during cystic fibrosis. The pathology
associated with cystic fibrosis is maintained by repeated lung
infections, mainly by Pseudomonas aeruginosa, which provokes
inflammatory responses that lead to lung fibrosis and respiratory failure (5, 6). Pulmonary injury is related to the production
of oxidants in the inflammatory environment that lead to necrosis of lung epithelial cells (3, 5), and infected epithelial cells
expressing mutant CFTR are less sensitive to apoptosis than
cells expressing normal CFTR (7). However, even in the absence of infection, inflammation is manifest in young children,
and inflammatory mediators are maintained constitutively at
high levels in cystic fibrosis patients (8 –10). Because cells
undergoing necrosis release debris that initiate inflammatory
responses, it is thus likely that cells expressing mutant CFTR
are also more resistant to apoptosis than normal cells in the
absence of infection. Consistent with this view, large DNA
fragments, typical of necrotic cells, are released in cystic fibrosis epithelia, thus increasing the viscosity of the mucus, and
inhaled DNase I improves the respiratory condition of cystic
fibrosis patients (11–15). In apoptotic cells, DNA is fragmented
into small fragments and packaged into apoptotic bodies that
are phagocytosed by neighboring cells, in a way that minimizes
an inflammatory response.
Recently it was shown that both the anionic tripeptide glutathione (␥-glutamyl-cysteinyl-glycine, GSH) as well as the
oxidized glutathione can permeate through the plasma membrane from the cytosol to the extracellular space via a CFTRdependent mechanism (1, 16, 17) thus establishing a possible
link between CFTR and antioxidant defenses of the lung. Glutathione is considered to be the most important water-soluble
antioxidant within cells. It keeps other antioxidants such as
␤-carotenes, tocopherols, and ascorbate in their reduced form,
and it functions in the reduction of hydrogen peroxide in reactions catalyzed by glutathione peroxidases (18). Glutathione is
also an important antioxidant in the lung (19, 20), and the GSH
1
The abbreviations used are: CFTR, cystic fibrosis transmembrane
conductance regulator; BSO, DL-buthionine sulfoximine; GSH, glutathione; GSHee, glutathione ethyl ester; FCS, fetal calf serum; FACS,
fluorescence-activated cell sorting; GFP, green fluorescent protein;
PBS, phosphate-buffered saline; BSA, bovine serum albumin; PE, phycoerythrin; TUNEL, terminal deoxynucleotidyl transferase-mediated
dUTP nick end labeling.

27912

This paper is available on line at http://www.jbc.org

Downloaded from http://www.jbc.org/ at Univ of the Pacific on April 17, 2017

Cystic fibrosis is characterized by chronic inflammation and an imbalance in the concentrations of alveolar
and lung oxidants and antioxidants, which result in cell
damage. Modifications in lung glutathione concentrations are recognized as a salient feature of inflammatory
lung diseases such as cystic fibrosis, and glutathione
plays a major role in protection against oxidative stress
and is important in modulation of apoptosis. The cystic
fibrosis transmembrane conductance regulator (CFTR)
is permeable to Clⴚ, larger organic ions, and reduced
and oxidized forms of glutathione, and the ⌬F508 CFTR
mutation found in cystic fibrosis patients has been correlated with impaired glutathione transport in cystic
fibrosis airway epithelia. Because intracellular glutathione protects against oxidative stress-induced apoptosis,
we studied the susceptibility of epithelial cells (HeLa
and IB3–1) expressing normal and mutant CFTR to apoptosis triggered by H2O2. We find that cells with normal
CFTR are more sensitive to oxidative stress-induced apoptosis than cells expressing defective CFTR. In addition,
sensitivity to apoptosis could be correlated with
glutathione levels, because depletion of intracellular
glutathione results in higher levels of apoptosis, and
glutathione levels decreased faster in cells expressing
normal CFTR than in cells with defective CFTR during
incubation with H2O2. The pro-apoptotic BCL-2 family
member, BAX, is also activated faster in cells expressing
normal CFTR than in those with mutant CFTR under
these conditions, and artificial glutathione depletion increases the extent of BAX activation. These results suggest that glutathione-dependent BAX activation in cells
with normal CFTR represents an early step in oxidative
stress-induced apoptosis of these cells.

Effect of CFTR on Apoptosis

EXPERIMENTAL PROCEDURES

Cells and Materials—HeLa cells were from the American Type Culture Collection (Manassas, VA). HeLa cells stably transfected with the
plasmid alone (pTracer), the wild-type CFTR construct (pTCFwt), the
CFTR ⌬F508 mutation (pTCF⌬F508), and the CFTR G551D mutation
(pTCFG551D) were prepared as previously described (30). The cells
were cultured in Dulbecco’s modified Eagle’s medium, supplemented
with 10% FCS, 2 mM glutamine, 100 g/ml streptomycin, 100 units/ml
penicillin and 250 g/ml Zeocin (all reagents were from Invitrogen) in
an incubator at 37 °C and 5% CO2. The starting cell lines were regularly
maintained in Plasmocin (Invitrogen).
IB3–1 CF airway epithelial cells (31) were grown in airway epithelial
cell growth medium KIT from PromoCell (Heidelberg, Germany) containing the Supplement Pack without epinephrine-250 and RA-50 and
supplemented with 10% FCS, 100 g/ml streptomycin, and 100 units/ml
penicillin.
Measurement of Apoptosis—HeLa cells at 70% confluency were incubated with H2O2 at the indicated concentrations for different times by
diluting the H2O2 directly into the cell culture medium. Both adherent
cells and cells in supernatant were collected, washed, and prepared for
cytofluorimetry. Annexin V-PE (BD PharMingen) was used to identify
apoptotic cells, following the manufacturer’s instructions (32). The cells
were washed and transferred into 12- ⫻ 75-mm Falcon 2052 FACS
tubes (Becton Dickinson, San Jose, CA), and data from 10,000 HeLa
cells were collected on a FACScan flow cytometer (Becton Dickinson)
with an argon laser tuned to 488 nm. Cell death was quantified using
CellQuest software.
Transient Lipofection of IB3–1 CF Cells—Cells were plated at a
density of 2.5 ⫻ 105 cells in 60-mm Petri dishes 24 h before transfection
with the pTracer plasmid, the wild-type CFTR construct (pTCFwt), or
pTCF⌬F508 using the LipofectAMINE Plus reagent from Invitrogen
(San Diego, CA), following the manufacturer’s instructions. Cells in
each Petri dish were transfected with 500 l of cell culture medium, 2
g of plasmid DNA, 8 l of Plus reagent, and 15 l of LipofectAMINE
without FCS or antibiotics. After transfecting the cells for 4 h at 37 °C,
2 ml of cell culture medium containing 20% FCS, 100 g/ml streptomycin, and 100 units/ml penicillin was added to each dish. Transfection of

IB3–1 CF cells under these conditions yielded 40 –55% positively transfected cells, as determined by cytofluorimetry measurement of the
green fluorescent protein (GFP) fluorescence. Twenty-four hours after
transfection cells were incubated with the indicated concentrations of
H2O2 for an additional 24 h. Apoptosis was measured by cytofluorimetry using annexin V-PE, as above, but gating only on GFP-positive
cells.
Measurement of Intracellular Glutathione—A quantitative determination of the total intracellular glutathione was performed as described
by Tietze (33). Confluent HeLa cell monolayers in six-well plates were
collected in 0.5 ml of PBS, 1 mM EDTA. Glutathione extraction was
performed by treating the cell suspension with 0.2 equivalent volume of
a 5% sulfosalicylic acid solution on ice for 15 min and assaying the
supernatant reactions after centrifugation at 12,000 rpm in an Eppendorf 5415C centrifuge (stored at 4 °C until use). After glutathione
extraction, the protein concentration was determined by the Bradford
assay (Bio-Rad protein assay).
Samples were diluted 10-fold in a 100 mM sodium phosphate, 1 mM
EDTA buffer solution at pH 7.5, and 50 l per well were transferred to
a 96-well microplate. The following freshly prepared reagents were then
mixed at room temperature: 2.8 ml of 1 mM 5,5⬘-dithiobis-2-nitrobenzoic
acid (DTNB), 3.75 ml of 1 mM NADPH, 5.85 ml of 100 mM sodium
phosphate, 1 mM EDTA buffer, and 20 units of glutathione reductase
(reaction mixture). A range of reduced glutathione concentrations was
prepared on the same day in 100 mM sodium phosphate, 1 mM EDTA,
pH 7.5, with 0.02 equivalent volumes of 5% sulfosalicylic acid, and was
used for calibration by transferring 50 l per well to a 96-well microplate. One hundred microliters of reaction mixture was immediately
added to each well containing sample or standard, and the microplate
was placed on the microtiter plate reader using a 420-nm filter. The
samples were mixed for 5 s, and absorbance was read for 5 min.
Samples were compared with the calibration curve to determine the
glutathione concentration in each well.
Depletion of Intracellular Glutathione—DL-Buthionine sulfoximine
(BSO) and glutathione ethyl ester (GSHee) were from Sigma Chemical
Co. For depletion of intracellular glutathione, an HeLa cell monolayer
at 50% confluence was pretreated with 200 M BSO for 24 h before
incubating with H2O2 in the presence of the same concentration of BSO
(34). For reversal of glutathione depletion, the cells were treated with
200 M BSO and 3 mM GSHee for 24 h, changing the medium every
12 h, and then with H2O2 in the presence of the same concentrations of
BSO and GSHee (34).
Quantification of BAX Activation by Cytofluorimetry—A monolayer
of HeLa cells confluent at 70% was plated in six-well plates and incubated for the indicated times with H2O2 in culture medium. The cells
were then collected with PBS, 1 mM EDTA, and washed twice with PBS
by centrifugation. The pellet was resuspended in 50 l of 2 g/ml BAX
rabbit polyclonal IgG (BAX N-20, Santa Cruz Biotechnology, Santa
Cruz, CA) in PBS, 1% BSA, 0.05% saponin for 30 min, then washed with
PBS and resuspended in 50 l of PE-conjugated anti-rabbit polyclonal
IgG (1:200 dilution; from Molecular Probes, Eugene, OR) in PBS, 1%
BSA, 0.05% saponin for 20 min. Samples were washed and suspended
in PBS, transferred into 12- ⫻ 75-mm Falcon 2052 FACS tubes, and
analyzed on the FACScan flow cytometer and CellQuest software, as
above.
Visualization of BAX Activation by Confocal Microscopy—HeLa cells
were cultured on microscope slides in six-well plates. After treatment
with 90 M H2O2 for 8 h, the supernatant was removed and cells were
fixed with 4% paraformaldehyde (35). Fixation was stopped by adding
the same volume of 50 mM NH4Cl in PBS for 20 min. Slides were
washed in PBS and incubated with 2 g/ml BAX rabbit polyclonal IgG
in PBS, 1% BSA, 0.05% saponin for 45 min, then washed with PBS and
incubated with 10 g/ml of fluorescein isothiocyanate-labeled antirabbit polyclonal IgG (Immunotech) in PBS, 0.05% saponin for 15 min.
A monoclonal antibody against mitochondrial hsp70 (Affinity Bioreagents, Golden, CO) was used at a dilution of 1:100, followed by a
Cy3-conjugated second antibody at a 1:100 dilution. The microscope
slides were rinsed in PBS, air-dried, and mounted with Dako mounting
medium. Samples were examined with a Leica confocal microscope
(Institut Jacques Monod, Paris), and images were analyzed with Adobe
Photoshop software.
RESULTS

Sensitivity to Oxidative Stress-induced Apoptosis of HeLa
Epithelial Cells Expressing Mutant and Normal CFTR—The
CFTR contains several functional domains, including hydrophobic regions thought to interact with membranes, a regula-
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concentration is greatly reduced in airway surface fluid of
cystic fibrosis patients (21). These defects can be attributed
directly to missing or defective CFTR channels, because the
glutathione concentration in the lung epithelial lining fluid of
CFTR-deficient mice is decreased by half, compared with that
in wild-type mice (22). The oxidative stress that results from
chronic inflammation in the lungs of cystic fibrosis patients
could thus be exacerbated by the decrease in GSH levels.
Because glutathione effluxes through the CFTR directly (1,
16) or indirectly (17), and depletion of cytosolic glutathione
contributes to apoptosis of lung epithelia and other tissues (23,
24), it has been proposed that the decreased ability of cells
expressing mutant CFTR to secrete glutathione may result in
their decreased ability to undergo apoptosis (3). Consistent
with this possibility, glutathione is actively extruded during
apoptosis of cells treated with reactive oxygen species (25).
To address directly the link between glutathione transport
by CFTR and apoptosis, we have measured apoptosis of epithelial cells expressing mutant and normal CFTR after exposure
to hydrogen peroxide. We have also measured the concentration of glutathione in the same cells as a function of time during
oxidative stress and have studied the effects of glutathione
depletion on apoptosis of the cells. Finally, because metabolic
or oxidative stress activates or induces expression of the proapoptotic BCL-2 family member BAX (26 –29), we also studied
activation of BAX in the different cells exposed to hydrogen
peroxide and the effect of glutathione depletion on BAX activation. Our results support the view that cells expressing normal CFTR are more sensitive to oxidative stress-induced apoptosis than cells expressing mutant CFTR because of enhanced
glutathione depletion in the normal cells. In addition, we propose that glutathione depletion results in BAX activation,
which is responsible for the subsequent apoptosis of normal
cells.
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tory region with several protein kinase substrate sites, and two
ATP-binding domains. The most common CFTR mutation associated with cystic fibrosis leads to omission of a phenylalanine residue (Phe-508) in a nucleotide binding region (36). We
therefore studied apoptosis induced by H2O2 in epithelial
(HeLa) cell lines stably transfected with the plasmid (pTracer),
the wild-type CFTR construct (pTCFwt), and the CFTR ⌬F508
mutation (pTCF⌬F508).
All cell lines showed a similar level of apoptosis after a 24-h
incubation in cell culture medium, but there was a significant
increase in apoptosis after treatment with 90 or 900 M H2O2
for 24 h (Fig. 1). Little enhancement of apoptosis due to 90 M
H2O2 was observed after 8 h, but wild-type cells displayed
higher levels of H2O2-induced apoptosis than pTracer or ⌬F508
after treatment with 90 M H2O2 for 24 h. The same tendency,
although at higher levels, was observed when the different cell
lines were exposed to 900 M H2O2 for 8 h or 24 h (Fig. 1). Thus,
HeLa cells expressing normal CFTR are more sensitive to

FIG. 2. Apoptosis of human airway epithelial cells expressing
wild-type or mutated CFTR after treatment with H2O2. A, cells
transfected transiently with plasmid alone (pTracer), the wild-type
CFTR construct (wt), or the CFTR ⌬F508 construct were incubated with
90 M H2O2, and apoptosis was measured 24 h later. *, p ⬍ 0.001; **,
p ⬍ 0.01, for pTCFwt compared with pTCF⌬F508 or pTracer. B, the
same cells were incubated with 300 M H2O2, and apoptosis was measured 24 h later. *, p ⬍ 0.01; **, p ⬍ 0.02, for pTCFwt compared with
pTCF⌬F508 or pTracer. There was not a significant difference between
pTCF⌬F508 and pTracer. Apoptosis was measured by cytofluorimetry,
as described under “Experimental Procedures.” The experiment was
performed on three separate days, and the values represent the mean
and S.D. from the three experiments. For each experiment, the highest
value of apoptosis (for pTCFwt) was defined as 100 (15% apoptosis for
A, and 41% for B), and the other values were normalized with respect to
the value for pTCFwt.

oxidative stress-induced apoptosis than either cells expressing
plasmid alone or cells expressing the ⌬F508 mutation.
Sensitivity to Oxidative Stress-induced Apoptosis of Airway
Epithelial Cells Expressing Mutant and Normal CFTR—Sensitivity to H2O2-induced apoptosis was also measured in a
human airway epithelial cells from a cystic fibrosis patient
(IB3–1) (31) that were transiently transfected with pTracer,
pTCFwt, or pTCF⌬F508. This CF bronchial epithelial cell line
was incubated with 90 or 300 M H2O2, and apoptosis was
measured by cytofluorimetry using annexin V-PE staining, as
above for HeLa cells. Because the transfected cells also expressed GFP, apoptosis was measured only for the GFP-positive cells. After treatment with 90 M H2O2, IB3–1 cells expressing normal CFTR were significantly more sensitive to
apoptosis than cells expressing mutant CFTR (Fig. 2). There
was also a higher sensitivity of the CFTR-expressing cells to
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FIG. 1. Apoptosis of HeLa epithelial cells expressing wild-type
or mutated CFTR after treatment with H2O2. A, cells transfected
with plasmid alone (pTracer), the wild-type CFTR construct (wt) or the
CFTR ⌬F508 construct were plated at 70% confluence and cultured in
an incubator at 37 °C and 5% CO2 for 8 or 24 h. B, the same cells were
treated with 90 M H2O2 in the incubator, and apoptosis was measured
8 or 24 h later, as indicated. *, p ⬍ 0.01; **, p ⬍ 0.1, for pTCFwt
compared with pTracer at 8 h, or pTCFwt compared with pTracer or
pTCF⌬F508 at 24 h. C, the same cells were incubated with 900 M H2O2
in the incubator, and apoptosis was measured 8 or 24 h later. *, p ⬍
0.01, for pTCFwt compared with pTracer at 8 h, or pTCFwt compared
with pTracer or pTCF⌬F508 at 24 h. Apoptosis was measured by
cytofluorimetry with annexin V-PE staining, as described under “Experimental Procedures.” The experiments were performed on at least
two separate days, and the values represent the mean and S.D. of
separate measurements.

Effect of CFTR on Apoptosis

apoptosis induced by 300 M H2O2, but the difference between
wild-type and mutant CFTR became smaller.
Effect of Glutathione Levels on Oxidative Stress-induced Apoptosis in Cells Expressing Mutant and Normal CFTR—Glutathione protects cells against oxidative damage and other types
of toxicity that could lead to apoptosis (18). Moreover, H2O2
induces apoptosis in many cell types, including epithelial cells,
and H2O2-mediated apoptosis is inhibited by intracellular glutathione (37– 42). To evaluate whether glutathione levels could
correlate with sensitivity to H2O2-induced apoptosis in our
cells, the relative glutathione concentration was measured for
the HeLa cell lines transfected with plasmid (pTracer) or expressing wild-type CFTR. The basal glutathione concentration
was reproducibly lower in cells expressing normal CFTR than
vector alone, and glutathione levels decreased faster in wildtype than control cells after treatment with 90 M H2O2 (Fig.
3), suggesting that wild-type cells lose intracellular glutathione
due to CFTR-dependent transport during oxidative stress.
Glutathione is synthesized by ␥-glutamylcysteine synthetase
and glutathione synthetase. Buthionine sulfoximine (BSO) is
an irreversible inhibitor of ␥-glutamylcysteine synthetase and
is often used to inhibit glutathione synthesis (18). A large
decrease in the intracellular concentration of glutathione was
observed after treatment of HeLa cells with BSO, in the absence of H2O2 (Fig. 3). Because the glutathione depletion by
BSO was equally effective in cells expressing wild-type CFTR
and no CFTR, the effect of BSO was then tested on the sensitivity to H2O2-induced apoptosis of wild-type cells. BSO treatment by itself had no effect on the level of spontaneous apoptosis, but it increased dramatically the extent of apoptosis
after incubation with H2O2 (Fig. 4). In addition, the effect was
reversible, because it could be counteracted by the presence of
GSHee, which prevents BSO-dependent glutathione depletion.
Cells expressing wild-type CFTR are, therefore, more sensitive
to H2O2-induced apoptosis at least in part due to the lower
intracellular glutathione concentration in wild-type cells. Like-

FIG. 4. Effect of intracellular glutathione concentration on
apoptosis of epithelial cells. HeLa cells expressing wild-type CFTR
were incubated with BSO alone; 90 M H2O2 alone; BSO and 90 M
H2O2; or BSO, GSHee, and 90 M H2O2. BSO by itself had no effect on
the level of apoptosis but enhanced the level of apoptosis of cells treated
with H2O2 for 24 h; the effect of BSO could be reversed by GSHee. p ⬍
0.01 for all points. Apoptosis was measured by cytofluorimetry, as
described under “Experimental Procedures.” The experiment was performed on two separate days, and the values represent the mean and
S.D. of three separate measurements.

wise, the sensitivity to apoptosis could be exacerbated through
artificial depletion of intracellular glutathione.
BAX Activation in Cells Expressing Mutant and Normal
CFTR—We then explored the possibility that enhanced depletion of glutathione in CFTR-expressing cells could cause BAX
to be activated faster than in cells with defective CFTR. The
state of BAX activation was detected by immunofluorescence
and cytofluorimetry using an antibody that is specific for an
N-terminal epitope that becomes exposed during activation
of BAX and its translocation from the cytosol to mitochondria
(28, 43).
In wild-type cells in the absence of H2O2 treatment, there
was only faint labeling of BAX, suggesting that the BAX was
present mostly in the cytosol. Following incubation with 90 M
H2O2 for 8 h, the fluorescence labeling of BAX became more
intense, as expected for BAX activation, and most of the protein
was localized on organelle structures that expressed a mitochondrial heat-shock protein (Fig. 5). Thus, oxidative stress
causes BAX to become activated in epithelial cells and to translocate to mitochondria.
The ability of H2O2 to activate BAX was then tested in
pTracer, wild-type CFTR cells, ⌬F508, and cells expressing
another CFTR mutation, G551D. The G551D mutation is less
common than ⌬F508, but it traffics normally to the plasma
membrane, unlike ⌬F508, most of which is processed improperly and remains within the cell (44). There was no significant
increase in BAX activation in any of the cell lines after a 2-h
incubation with 90 M H2O2, but a large increase in BAX
activation was already observed in wild-type cells after 4 h
(Fig. 6). Some BAX activation, reaching 20%, was measured in
all cell types after 8 h of H2O2 treatment, at which time 40% of
wild-type cells contained activated BAX. Oxidative stress is
therefore able to activate BAX in epithelial cells, and BAX is
activated faster in cells expressing normal CFTR than in cells
expressing defective CFTR.
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FIG. 3. Concentration of intracellular glutathione in cells
without CFTR or cells expressing wild-type CFTR after incubation with H2O2 or BSO. The intracellular glutathione concentration
in HeLa cells expressing wild-type CFTR (black bars) or no CFTR (white
bars) was measured as a function of time, after addition of 90 M H2O2.
As a control for intracellular glutathione depletion, the cells were also
preincubated with BSO for 24 h in the absence of H2O2. *, p ⬍ 0.02; **,
p ⬍ 0.05, for pTCFwt compared with pTracer; the values at the other
time points are not significantly different. The glutathione concentration was measured as described under “Experimental Procedures.” The
experiment was performed on three separate days, and one representative experiment out of three is shown. The values represent the mean
and S.D. of two separate measurements.
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FIG. 7. Effect of intracellular glutathione concentration on
BAX activation in epithelial cells. HeLa cells expressing wild-type
CFTR were incubated with BSO; 90 M H2O2; BSO and 90 M H2O2; or
BSO, GSHee, and 90 M H2O2, as indicated in the x-axis legend. BSO by
itself had no effect on the level of BAX activation but enhanced the
extent of activation in cells treated with H2O2 for 6 h; the effect of BSO
could be reversed by GSHee. p ⬍ 0.02 for cells treated with H2O2,
compared with control untreated cells; to cells treated with H2O2 and
BSO; or to cells treated with H2O2, BSO, and GSHee. BAX activation
was measured by cytofluorimetry, as described under “Experimental
Procedures.” The experiment was performed on two separate days,
and the values represent the mean and S.D. of three separate
measurements.

tent to which H2O2 promotes BAX activation in epithelial
cells. Because there is significant BAX activation in H2O2treated cells within 4 h (Fig. 6), at which time there is still
only a low level of apoptosis (Fig. 1), these results suggest
that glutathione-dependent BAX activation precedes apoptosis of these cells during oxidative stress.
DISCUSSION

FIG. 6. BAX activation in cells expressing wild-type or mutated
CFTR as a function of time after treatment with H2O2. BAX
activation in HeLa cells stably transfected with plasmid (black bars),
wild-type CFTR (white bars), ⌬F508 CFTR (gray bars), or G551D CFTR
(striped bars) was measured as a function of time after addition of 90 M
H2O2. *, p ⬍ 0.05; **, p ⬍ 0.02; and ***, p ⬍ 0.01, for pTCFwt compared
with pTCF⌬F508 for each time point. BAX activation was measured
with the N-20 antibody by cytofluorimetry, as described under “Experimental Procedures.” The experiment was performed on two separate
days, and the values represent the mean and S.D. of three separate
measurements.

Effect of Depletion of Glutathione Levels on BAX Activation—The possible correlation between glutathione levels
and BAX activation was then investigated by measuring BAX
activation by cytofluorimetry in wild-type cells treated with
90 M H2O2 for 6 h. In cells depleted of glutathione by BSO,
oxidative stress induced BAX activation to a higher extent
than in the absence of depletion, and the enhancement of
apoptosis by BSO could be reversed by GSHee (Fig. 7). Intracellular glutathione concentrations therefore control the ex-

Cystic fibrosis was originally thought to be due to CFTR
mutations that impair Cl⫺ channel activity. However, additional CFTR functions modified by the mutations were later
identified, affecting notably Cl⫺-coupled HCO3⫺ transport (45–
47), and CFTR may also transport ions and molecules other
than Cl⫺, including both the oxidized and reduced forms of
glutathione (1, 16).
CFTR-dependent Cl⫺-coupled HCO3⫺ transport could potentially modify cytosolic and extracellular pH, and CFTR mutations have been associated with defects in tissue acidification
(45). Cytosolic acidification is also an early step in many pathways of apoptosis (28, 29, 48 –50), suggesting that CFTR mutations could affect cell sensitivity to apoptosis. A number of
reports are in fact consistent with the view that inappropriate
apoptosis due to decreased cytosolic acidification may contribute to the symptoms of cystic fibrosis (51–53). However, contradictory results were also obtained (54, 55).
Thus, it was first reported that mammary epithelial cells
(C127) expressing normal CFTR are more sensitive to apoptosis due to treatment with the protein synthesis inhibitor, cycloheximide, than cells expressing mutant (⌬F508) CFTR, and
that the cytosol is acidified to a larger extent in cells expressing
normal CFTR (53). The mechanism of the apoptosis is not clear,
because cycloheximide can both induce and inhibit apoptosis
(56) and could influence synthesis and intracellular transport
of CFTR. However, apoptosis of cells expressing mutant CFTR
is enhanced by treatment with the weak organic acid, propionic
acid, without affecting apoptosis of cycloheximide-treated cells
with normal CFTR (53), suggesting that acidification could
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FIG. 5. BAX activation and distribution in epithelial cells expressing wild-type CFTR after treatment with H2O2. Subcellular
localization of BAX in HeLa cells expressing wild-type CFTR, and the
same cells treated with 90 M H2O2 for 8 h. Weak BAX staining in the
cytosol is observed in untreated cells, while staining becomes more
intense and distributes to mitochondria after treatment with H2O2. The
antibody against BAX (N-20) recognizes an amino-terminal domain of
BAX that is exposed during BAX activation. BAX activation and distribution were visualized by confocal microscopy, as described under “Experimental Procedures.”
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under the control of a number of molecules, including the
BCL-2 family of proteins, which can either promote or inhibit
apoptosis (62). The BCL-2 group (e.g. BCL-2, BCL-xL, and
BCL-w) promotes cell survival, whereas the BAX group (e.g.
BAX, BAK, BAD, and BID) stimulates apoptosis. BAX exhibits
a cytosolic location before the cell receives an apoptotic stimulus, and it translocates from the cytosol to mitochondria during
apoptosis (28, 63). Activation of BAX causes release of cytochrome c from the mitochondria (64), which associates with
Apaf-1 and procaspase-9 in the cytosol, resulting in activation
of caspase-9 and, subsequently, in activation of caspase-3. This
effector caspase then degrades cytosolic, nuclear, and cytoskeletal proteins, activates a caspase-dependent nuclease, and is
responsible for many of the morphological and biochemical
features of apoptosis (65– 67).
It has been shown that cytosolic depletion of glutathione, a
common event in damage-induced apoptosis, is necessary and
sufficient to induce cytochrome c release (23), which would
therefore lead to caspase-9 and caspase-3 activation, and finally cell death. We find that a downstream effect of glutathione depletion is BAX activation, which is found in the cytosol of
untreated cells but translocates to the mitochondria after treatment with H2O2. In cells expressing normal CFTR, BAX is
activated significantly faster than in cells expressing mutant
CFTR after treatment with H2O2. BSO increases the extent of
BAX activation in cells treated with H2O2, and the effect is
reversed by GSHee, suggesting that BAX activation represents
an early step in oxidation-induced apoptosis. Because BAX may
also be activated by cytosolic pH changes (28, 29, 43), it is thus
likely that both decreased cytosol acidification and slower glutathione depletion may result in the higher resistance to apoptosis observed in cells expressing defective or missing CFTR.
Taken together, these results suggest that slower glutathione
export and, consequently, delayed cell death of cells expressing
mutant CFTR could contribute to the chronic inflammation
observed in cystic fibrosis patients.
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play a role in this process. The same laboratory subsequently
found that the CFTR affects proliferation but not apoptosis of
epithelial cells lining the gastrointestinal tract in mice, and
that CFTR does not affect the susceptibility of C127 cell lines to
UV irradiation-induced apoptosis (55). The effects of CFTR on
apoptosis or proliferation of airway epithelial cells in the mice
were not reported, and the possible link between oxidative
stress and CFTR-dependent apoptosis was not investigated
(55). Finally, an older study (51) suggests that mutant CFTR
may, on the contrary, increase the number of cells with fragmented DNA in the lung, as determined by in situ terminal
deoxynucleotidyltransferase-mediated dUTP-digoxigenin nickend labeling (TUNEL) of DNA in tissues from cystic fibrosis
and control patients. Only two out of fourteen cystic fibrosis
patients had the ⌬F508/⌬F508 mutation (51), and a larger
group of patients should therefore be studied to determine
conclusively if this mutation has an effect on cell death in
humans. Nonetheless, as both apoptotic and necrotic cells contain free DNA ends that can be labeled with the terminal
deoxynucleotidyltransferase (57–59), many if not all of the
TUNEL-positive cells observed in the human lung tissues could
have been necrotic.
Direct evidence for a link between CFTR and pH-dependent
apoptosis was recently obtained with fibroblasts expressing
transfected CFTR, which are significantly more sensitive to
lovastatin-mediated apoptosis than untransfected controls
(52). Lovastatin treatment causes cytosolic pH to decrease, and
blocking intracellular acidification through overexpression of a
Na⫹/H⫹ exchanger or increasing extracellular pH inhibits the
enhancement of apoptosis induced by CFTR. It was proposed
that CFTR enhances apoptosis through modulation of the C⫺/
HCO3⫺ exchanger activity (52).
In line with the observations from other laboratories, we find
that the cytosolic pH becomes acidic faster in cells expressing
normal CFTR than in cells expressing mutant CFTR after
treatment with H2O2.2 In the present report, we evaluate the
possibility that CFTR-dependent glutathione transport could
contribute to differential sensitivity to apoptosis due to oxidative stress. Synthesis of reduced glutathione takes place in the
cytoplasm, which contains glutathione concentrations of 1–10
mM (60). Faster extrusion of glutathione in cells expressing
normal CFTR could therefore account for their higher sensitivity to apoptosis, compared with cells expressing defective or
missing CFTR.
For both HeLa epithelial cells and human airway epithelial
cells from a cystic fibrosis patient (IB3–1), we find that cells
expressing normal CFTR display a significantly higher sensitivity to apoptosis due to H2O2 treatment than cells expressing
no CFTR or cells expressing the ⌬F508 mutation, the most
common mutation of the CFTR in cystic fibrosis patients. At
the same time, cells treated with H2O2 become depleted of
cytosolic glutathione, and cells displaying normal CFTR are
depleted faster than cells expressing mutant or no CFTR. Glutathione depletion in these cells correlates with the onset of
apoptosis, because depleting glutathione further with BSO renders all the cells more sensitive to H2O2-induced apoptosis;
inhibiting the depletion with GSHee restores the original
sensitivity.
We then studied the mechanism whereby lower glutathione
concentrations could lead to more apoptosis in normal cells.
Apoptosis can be triggered via ligation of surface receptors such
as Fas (61), but it can also be initiated from within the cell due
to metabolic or oxidative stress. Stress-induced apoptosis is

27917

27918

Effect of CFTR on Apoptosis
Y. A. (1998) J. Biol. Chem. 273, 11313–11320
43. Pawlowski, J., and Kraft, A. S. (2000) Proc. Natl. Acad. Sci. U. S. A. 97,
529 –531
44. Welsh, M. J., and Smith, A. E. (1993) Cell 73, 1251–1254
45. Choi, J. Y., Muallem, D., Kiselyov, K., Lee, M. G., Thomas, P. J., and Muallem,
S. (2001) Nature 410, 94 –97
46. Clarke, L. L., and Harline, M. C. (1998) Am. J. Physiol. 274, G718 –G726
47. Illek, B., Yankaskas, J. R., and Machen, T. E. (1997) Am. J. Physiol. 272,
L752–L761
48. Matsuyama, S., Llopis, J., Deveraux, Q. L., Tsien, R. Y., and Reed, J. C. (2000)
Nat. Cell Biol. 2, 318 –325
49. Li, J., and Eastman, A. (1995) J. Biol. Chem. 270, 3203–3211
50. Perez-Sala, D., Collado-Escobar, D., and Mollinedo, F. (1995) J. Biol. Chem.
270, 6235– 6242
51. Maiuri, L., Raia, V., De Marco, G., Coletta, S., de Ritis, G., Londei, M., and
Auricchio, S. (1997) FEBS Lett. 408, 225–231
52. Barriere, H., Poujeol, C., Tauc, M., Blasi, J. M., Counillon, L., and Poujeol, P.
(2001) Am. J. Physiol. 281, C810 –C824
53. Gottlieb, R. A., and Dosanjh, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93,
3587–3591
54. Kim, J. A., Kang, Y. S., Lee, S. H., Lee, E. H., Yoo, B. H., and Lee, Y. S. (1999)
Biochem. Biophys. Res. Commun. 261, 682– 688
55. Gallagher, A. M., and Gottlieb, R. A. (2001) Am. J. Physiol. 281, G681–G687
56. Golstein, P., Ojcius, D. M., and Young, J. D. (1991) Immunol. Rev. 121, 29 – 65
57. Grasl-Kraupp, B., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch,
W., and Schulte-Hermann, R. (1995) Hepatology 21, 1465–1468
58. Charriaut-Marlangue, C., and Ben-Ari, Y. (1995) Neuroreport 7, 61– 64
59. Yasuda, M., Umemura, S., Osamura, R. Y., Kenjo, T., and Tsutsumi, Y. (1995)
Arch. Histol. Cytol. 58, 185–190
60. Smith, C. V., Jones, D. P., Guenther, T. M., Lash, L. H., and Lauterberg, B. H.
(1996) Toxicol. Appl. Pharmacol. 140, 1–12
61. Nagata, S. (1997) Cell 88, 355–365
62. Adams, J. M., and Cory, S. (1998) Science 281, 1322–1326
63. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle,
R. J. (1997) J. Cell Biol. 139, 1281–1292
64. Shimizu, S., Narita, M., and Tsujimoto, Y. (1999) Nature 399, 483– 487
65. Cohen, G. M. (1997) Biochem. J. 326, 1–16
66. Salvesen, G. S., and Dixit, V. M. (1997) Cell 91, 443– 446
67. Nicholson, D. W., and Thornberry, N. A. (1997) Trends Biochem. Sci. 22,
299 –306

Downloaded from http://www.jbc.org/ at Univ of the Pacific on April 17, 2017

21. Roum, J. H., Buhl, R., McElvaney, N. G., Borok, Z., and Crystal, R. G. (1993)
J. Appl. Physiol. 75, 2419 –2424
22. Velsor, L. W., van Heeckeren, A., and Day, B. J. (2001) Am. J. Physiol. 281,
L31–L38
23. Coppola, S., and Ghibelli, L. (2000) Biochem. Soc. Trans. 28, 56 – 61
24. Rahman, Q., Abidi, P., Afaq, F., Schiffmann, D., Mossman, B. T., Kamp, D. W.,
and Athar, M. (1999) Crit. Rev. Toxicol. 29, 543–568
25. Ghibelli, L., Coppola, S., Rotilio, G., Lafavia, E., Maresca, V., and Ciriolo, M. R.
(1995) Biochem. Biophys. Res. Commun. 216, 313–320
26. Ho, Y. S., Lee, H. M., Mou, T. C., Wang, Y. J., and Lin, J. K. (1997) Mol.
Carcinogenesis 19, 101–113
27. Nakamura, T., and Sakamoto, K. (2001) Biochem. Biophys. Res. Commun. 284,
203–210
28. Khaled, A. R., Kim, K., Hofmeister, R., Muegge, K., and Durum, S. K. (1999)
Proc. Natl. Acad. Sci. U. S. A. 96, 14476 –14481
29. Belaud-Rotureau, M. A., Leducq, N., Macouillard Poulletier de Gannes, F.,
Diolez, P., Lacoste, L., Lacombe, F., Bernard, P., and Belloc, F. (2000)
Apoptosis 5, 551–560
30. Clain, J., Fritsch, J., Lehmann-Che, J., Bali, M., Arous, N., Goossens, M.,
Edelman, A., and Fanen, P. (2001) J. Biol. Chem. 276, 9045–9049
31. Zeitlin, P. L., Lu, L., Rhim, J., Cutting, G., Stetten, G., Kieffer, K. A., and
Craig, R. (1991) Am. J. Respir. Cell Mol. Biol. 4, 313–319
32. Schmid, I., Krall, W. J., Uittenbogaart, C. H., Braun, J., and Giorgi, J. V.
(1992) Cytometry 13, 204 –208
33. Tietze, F. (1969) Anal. Biochem. 27, 502–522
34. Celli, A., Que, F. G., Gores, G. J., and LaRusso, N. F. (1998) Am. J. Physiol.
275, G749 –G757
35. Ojcius, D. M., Niedergang, F., Subtil, A., Hellio, R., and Dautry-Varsat, A.
(1996) Res. Immunol. 147, 175–188
36. Riordan, J. R., Rommens, J. M., Kerem, B., Alon, N., Rozmahel, R., Grzelczak,
Z., Zielenski, J., Lok, S., Plavsic, N., and Chou, J. L. (1989) Science 245,
1066 –1073
37. Hultberg, B., Andersson, A., and Isaksson, A. (1999) Clin. Chim. Acta 283,
21–32
38. Morcillo, E. J., Estera, J., and Cortijo, J. (1999) Pharmacol. Res. 40, 393– 404
39. Hall, A. G. (1999) Eur. J. Clin. Invest. 29, 238 –245
40. Nakajima, Y., Aoshiba, K., Yasui, S., and Nagai, A. (1999) Life Sci. 64,
2489 –2496
41. Aoshiba, K., Yasui, S., Nishimura, K., and Nagai, A. (1999) Am. J. Respir. Cell
Mol. Biol. 21, 54 – 64
42. Liu, B., Andrieu-Abadie, N., Levade, T., Zhang, P., Obeid, L. M., and Hannum,

Glutathione Levels and BAX Activation during Apoptosis Due to Oxidative Stress in
Cells Expressing Wild-type and Mutant Cystic Fibrosis Transmembrane
Conductance Regulator
Thomas Jungas, Iris Motta, Francis Duffieux, Pascale Fanen, Véronique Stoven and David
M. Ojcius
J. Biol. Chem. 2002, 277:27912-27918.
doi: 10.1074/jbc.M110288200 originally published online May 22, 2002

Access the most updated version of this article at doi: 10.1074/jbc.M110288200

Click here to choose from all of JBC's e-mail alerts
This article cites 67 references, 19 of which can be accessed free at
http://www.jbc.org/content/277/31/27912.full.html#ref-list-1

Downloaded from http://www.jbc.org/ at Univ of the Pacific on April 17, 2017

Alerts:
• When this article is cited
• When a correction for this article is posted

